The 22q11 deletion syndrome (22q11DS), or velocardiofacial/DiGeorge syndrome, is considered to be the second most known genetic cause of congenital heart disease (CHD).
Screening for 22q11 deletion syndrome among patients with congenital heart defects
Triagem para a síndrome de deleção 22q11 entre pacientes com cardiopatia congênita The 22q11 deletion syndrome (22q11DS), or velocardiofacial/DiGeorge syndrome, is considered to be the second most known genetic cause of congenital heart disease (CHD). 1 Our aim was to evaluate the effectiveness of different screening methods for 22q11DS in patients with CHD. Our study evaluated a consecutive sample of patients with CHD hospitalized for the first time in a pediatric and cardiac intensive care unit of a referral hospital in southern Brazil.
All of them underwent the examination through fluorescent in situ hybridization for 22q11DS.
These patients were part of the study by Rosa et al. 2 CHDs were classified by a cardiologist as conotruncal or non-conotruncal. We excluded patients with other chromosomal abnormalities.
Three different approaches composed the screening:
(1) Testing suggested by Tobias et al. 3 The clinical findings are divided into three categories: For all these approaches, we calculated the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and receiver operating characteristic (ROC) curves. The significance level used was 5% (P ≤ 0.05). The total sample consisted of 170 patients (93 males), with ages ranging from 1 to 4934 days (mean of 847.7 days, standard deviation of 1225.1).
22q11DS was identified in four patients (2.4%): two newborns with TOF, one newborn with VSD associated with AAA, and one adolescent with atrial septal defect. One hundred and eleven patients (65%) met screening criterion 1, with sensitivity 100%, specificity 36%, PPV 3.6% and NPV 100%. Criterion 2 was met by 76 (44.7%) patients, with sensitivity 75%, specificity 56%, PPV 3.9% and NPV 98.9%. Forty-five patients (26.5%) had conotruncal heart defects and fulfilled criterion 3, with sensitivity 50%, specificity 74%, PPV 4.4% and NPV 98.4%. The ROC curves are shown in Figure 1 . All the areas under the ROC curves were less than 0. 
(1) Figure 1 . Receiver operating characteristic (ROC) curves presented by the different screening criteria.
